{"slug":"bakerbros","name":"Baker Bros. Advisors","style":"sector_healthcare","grade":"A","book":[{"ticker":"INCY","issuer":"Incyte Corporation","shares":30744412.0,"value_usd":2893664057.0,"pct_book":16.62,"position_rank":1,"tilt_pp":15.404,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[{"key":"us_sector_health","name":"Health Care (Equal-Weight)","name_zh":"\u533b\u7597\u4fdd\u5065\uff08\u7b49\u6743\uff09"}],"since_excess":0.2095,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":70.0,"tier":"high","components":{"pct_book":{"value":1.0,"points":35.0},"rank_top10":{"value":1,"points":15.0},"tilt":{"value":15.404,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ONC","issuer":"BeOne Medicines Ltd.","shares":8799053.0,"value_usd":2613054769.0,"pct_book":15.0,"position_rank":2,"tilt_pp":13.793,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":69.6,"tier":"moderate","components":{"pct_book":{"value":0.988,"points":34.57},"rank_top10":{"value":2,"points":15.0},"tilt":{"value":13.793,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"INSM","issuer":"Insmed Incorporated","shares":7421111.0,"value_usd":1213500071.0,"pct_book":6.97,"position_rank":3,"tilt_pp":5.757,"action":"add","shares_change_pct":12.6,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":74.1,"tier":"high","components":{"pct_book":{"value":0.976,"points":34.15},"rank_top10":{"value":3,"points":15.0},"tilt":{"value":5.757,"points":10.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MDGL","issuer":"Madrigal Pharmaceuticals, Inc.","shares":2141701.0,"value_usd":1121116222.0,"pct_book":6.44,"position_rank":4,"tilt_pp":5.226,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":68.7,"tier":"moderate","components":{"pct_book":{"value":0.963,"points":33.72},"rank_top10":{"value":4,"points":15.0},"tilt":{"value":5.226,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ACAD","issuer":"ACADIA Pharmaceuticals Inc.","shares":42896690.0,"value_usd":954880319.0,"pct_book":5.48,"position_rank":5,"tilt_pp":4.272,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":0.1685,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":68.3,"tier":"moderate","components":{"pct_book":{"value":0.951,"points":33.29},"rank_top10":{"value":5,"points":15.0},"tilt":{"value":4.272,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RVMD","issuer":"Revolution Medicines, Inc.","shares":9555357.0,"value_usd":929258468.0,"pct_book":5.34,"position_rank":6,"tilt_pp":4.125,"action":"hold","shares_change_pct":1.1,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":67.9,"tier":"moderate","components":{"pct_book":{"value":0.939,"points":32.87},"rank_top10":{"value":6,"points":15.0},"tilt":{"value":4.125,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CELC","issuer":"Celcuity Inc.","shares":7915792.0,"value_usd":903508499.0,"pct_book":5.19,"position_rank":7,"tilt_pp":3.977,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":67.4,"tier":"moderate","components":{"pct_book":{"value":0.927,"points":32.44},"rank_top10":{"value":7,"points":15.0},"tilt":{"value":3.977,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"KOD","issuer":"Kodiak Sciences Inc.","shares":19919186.0,"value_usd":759319370.0,"pct_book":4.36,"position_rank":8,"tilt_pp":3.149,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":67.0,"tier":"moderate","components":{"pct_book":{"value":0.915,"points":32.01},"rank_top10":{"value":8,"points":15.0},"tilt":{"value":3.149,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"KYMR","issuer":"Kymera Therapeutics, Inc.","shares":8657242.0,"value_usd":721061686.0,"pct_book":4.14,"position_rank":9,"tilt_pp":2.929,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":66.6,"tier":"moderate","components":{"pct_book":{"value":0.902,"points":31.59},"rank_top10":{"value":9,"points":15.0},"tilt":{"value":2.929,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SMMT","issuer":"Summit Therapeutics Inc.","shares":36391063.0,"value_usd":689974554.0,"pct_book":3.96,"position_rank":10,"tilt_pp":2.751,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":66.2,"tier":"moderate","components":{"pct_book":{"value":0.89,"points":31.16},"rank_top10":{"value":10,"points":15.0},"tilt":{"value":2.751,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"PRAX","issuer":"Praxis Precision Medicines, Inc.","shares":1753198.0,"value_usd":564862864.0,"pct_book":3.24,"position_rank":11,"tilt_pp":2.032,"action":"add","shares_change_pct":55.6,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":60.7,"tier":"moderate","components":{"pct_book":{"value":0.878,"points":30.73},"rank_top10":{"value":11,"points":0.0},"tilt":{"value":2.032,"points":10.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RYTM","issuer":"Rhythm Pharmaceuticals, Inc.","shares":5604483.0,"value_usd":487421887.0,"pct_book":2.8,"position_rank":12,"tilt_pp":1.588,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":50.3,"tier":"moderate","components":{"pct_book":{"value":0.866,"points":30.3},"rank_top10":{"value":12,"points":0.0},"tilt":{"value":1.588,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALKS","issuer":"Alkermes plc","shares":10012267.0,"value_usd":354033761.0,"pct_book":2.03,"position_rank":13,"tilt_pp":0.822,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":0.376,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":49.9,"tier":"moderate","components":{"pct_book":{"value":0.854,"points":29.88},"rank_top10":{"value":13,"points":0.0},"tilt":{"value":0.822,"points":10.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GRAL","issuer":"GRAIL, Inc.","shares":4028614.0,"value_usd":208198772.0,"pct_book":1.2,"position_rank":14,"tilt_pp":-0.016,"action":"add","shares_change_pct":93.2,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":49.5,"tier":"moderate","components":{"pct_book":{"value":0.841,"points":29.45},"rank_top10":{"value":14,"points":0.0},"tilt":{"value":-0.016,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EWTX","issuer":"Edgewise Therapeutics, Inc.","shares":6575940.0,"value_usd":207142110.0,"pct_book":1.19,"position_rank":15,"tilt_pp":-0.022,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":39.0,"tier":"low","components":{"pct_book":{"value":0.829,"points":29.02},"rank_top10":{"value":15,"points":0.0},"tilt":{"value":-0.022,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IONS","issuer":"Ionis Pharmaceuticals, Inc.","shares":2047727.0,"value_usd":153763820.0,"pct_book":0.88,"position_rank":16,"tilt_pp":-0.328,"action":"add","shares_change_pct":14.3,"add_streak_q":3,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":53.6,"tier":"moderate","components":{"pct_book":{"value":0.817,"points":28.6},"rank_top10":{"value":16,"points":0.0},"tilt":{"value":-0.328,"points":0.0},"add_streak":{"value":3,"points":15.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"KNSA","issuer":"Kiniksa Pharmaceuticals International, plc","shares":2826246.0,"value_usd":136083745.0,"pct_book":0.78,"position_rank":17,"tilt_pp":-0.43,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.2,"tier":"low","components":{"pct_book":{"value":0.805,"points":28.17},"rank_top10":{"value":17,"points":0.0},"tilt":{"value":-0.43,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IMVT","issuer":"Immunovant, Inc.","shares":5457881.0,"value_usd":135573764.0,"pct_book":0.78,"position_rank":18,"tilt_pp":-0.433,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.2,"tier":"low","components":{"pct_book":{"value":0.805,"points":28.17},"rank_top10":{"value":18,"points":0.0},"tilt":{"value":-0.433,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ROIV","issuer":"Roivant Sciences Ltd.","shares":4867723.0,"value_usd":134835927.0,"pct_book":0.77,"position_rank":19,"tilt_pp":-0.437,"action":"trim","shares_change_pct":-12.4,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":0.1586,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":37.3,"tier":"low","components":{"pct_book":{"value":0.78,"points":27.32},"rank_top10":{"value":19,"points":0.0},"tilt":{"value":-0.437,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IDYA","issuer":"IDEAYA Biosciences, Inc.","shares":3946515.0,"value_usd":131497880.0,"pct_book":0.76,"position_rank":20,"tilt_pp":-0.456,"action":"hold","shares_change_pct":9.1,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":36.9,"tier":"low","components":{"pct_book":{"value":0.768,"points":26.89},"rank_top10":{"value":20,"points":0.0},"tilt":{"value":-0.456,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ARWR","issuer":"Arrowhead Pharmaceuticals, Inc.","shares":1992783.0,"value_usd":124947494.0,"pct_book":0.72,"position_rank":21,"tilt_pp":-0.494,"action":"hold","shares_change_pct":-8.4,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":-0.0694,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":36.5,"tier":"low","components":{"pct_book":{"value":0.756,"points":26.46},"rank_top10":{"value":21,"points":0.0},"tilt":{"value":-0.494,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"STOK","issuer":"Stoke Therapeutics, Inc.","shares":3336697.0,"value_usd":108642854.0,"pct_book":0.62,"position_rank":22,"tilt_pp":-0.587,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":36.0,"tier":"low","components":{"pct_book":{"value":0.744,"points":26.04},"rank_top10":{"value":22,"points":0.0},"tilt":{"value":-0.587,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABCL","issuer":"AbCellera Biologics Inc.","shares":30275938.0,"value_usd":105663024.0,"pct_book":0.61,"position_rank":23,"tilt_pp":-0.605,"action":"hold","shares_change_pct":10.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":35.6,"tier":"low","components":{"pct_book":{"value":0.732,"points":25.61},"rank_top10":{"value":23,"points":0.0},"tilt":{"value":-0.605,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABVX","issuer":"Abivax S.A.","shares":875796.0,"value_usd":97519885.0,"pct_book":0.56,"position_rank":24,"tilt_pp":-0.651,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":35.2,"tier":"low","components":{"pct_book":{"value":0.72,"points":25.18},"rank_top10":{"value":24,"points":0.0},"tilt":{"value":-0.651,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CRNX","issuer":"Crinetics Pharmaceuticals, Inc.","shares":2351465.0,"value_usd":85405209.0,"pct_book":0.49,"position_rank":25,"tilt_pp":-0.721,"action":"add","shares_change_pct":42.6,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":44.8,"tier":"low","components":{"pct_book":{"value":0.707,"points":24.76},"rank_top10":{"value":25,"points":0.0},"tilt":{"value":-0.721,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"REPL","issuer":"Replimune Group, Inc.","shares":11045336.0,"value_usd":84496820.0,"pct_book":0.49,"position_rank":26,"tilt_pp":-0.726,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.8,"tier":"low","components":{"pct_book":{"value":0.707,"points":24.76},"rank_top10":{"value":26,"points":0.0},"tilt":{"value":-0.726,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CELC 2.75 08-01-31","issuer":"Celcuity Inc.","shares":30750000.0,"value_usd":74868563.0,"pct_book":0.43,"position_rank":27,"tilt_pp":-0.781,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":28.9,"tier":"low","components":{"pct_book":{"value":0.683,"points":23.9},"rank_top10":{"value":27,"points":0.0},"tilt":{"value":-0.781,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"NRIX","issuer":"Nurix Therapeutics, Inc.","shares":4658556.0,"value_usd":72207618.0,"pct_book":0.41,"position_rank":28,"tilt_pp":-0.797,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.5,"tier":"low","components":{"pct_book":{"value":0.671,"points":23.48},"rank_top10":{"value":28,"points":0.0},"tilt":{"value":-0.797,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DNLI","issuer":"Denali Therapeutics Inc.","shares":3731695.0,"value_usd":71648544.0,"pct_book":0.41,"position_rank":29,"tilt_pp":-0.8,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.5,"tier":"low","components":{"pct_book":{"value":0.671,"points":23.48},"rank_top10":{"value":29,"points":0.0},"tilt":{"value":-0.8,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DNTH","issuer":"Dianthus Therapeutics, Inc.","shares":852164.0,"value_usd":71513603.0,"pct_book":0.41,"position_rank":30,"tilt_pp":-0.801,"action":"hold","shares_change_pct":7.9,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.5,"tier":"low","components":{"pct_book":{"value":0.671,"points":23.48},"rank_top10":{"value":30,"points":0.0},"tilt":{"value":-0.801,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GLUE","issuer":"Monte Rosa Therapeutics, Inc.","shares":4345736.0,"value_usd":71487357.0,"pct_book":0.41,"position_rank":31,"tilt_pp":-0.801,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":33.5,"tier":"low","components":{"pct_book":{"value":0.671,"points":23.48},"rank_top10":{"value":31,"points":0.0},"tilt":{"value":-0.801,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"GPCR","issuer":"Structure Therapeutics Inc.","shares":1432529.0,"value_usd":69047898.0,"pct_book":0.4,"position_rank":32,"tilt_pp":-0.815,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[{"key":"obesity_glp1","name":"GLP-1 & Obesity","name_zh":"GLP-1 \u4e0e\u51cf\u80a5\u836f"}],"since_excess":0.2103,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.8,"tier":"low","components":{"pct_book":{"value":0.622,"points":21.77},"rank_top10":{"value":32,"points":0.0},"tilt":{"value":-0.815,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TRDA","issuer":"Entrada Therapeutics, Inc.","shares":5072730.0,"value_usd":64017853.0,"pct_book":0.37,"position_rank":33,"tilt_pp":-0.844,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.3,"tier":"low","components":{"pct_book":{"value":0.61,"points":21.34},"rank_top10":{"value":33,"points":0.0},"tilt":{"value":-0.844,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"BCYC","issuer":"Bicycle Therapeutics plc","shares":10885357.0,"value_usd":50508056.0,"pct_book":0.29,"position_rank":34,"tilt_pp":-0.921,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":30.9,"tier":"low","components":{"pct_book":{"value":0.598,"points":20.91},"rank_top10":{"value":34,"points":0.0},"tilt":{"value":-0.921,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SYRE","issuer":"Spyre Therapeutics, Inc.","shares":1000000.0,"value_usd":50440000.0,"pct_book":0.29,"position_rank":35,"tilt_pp":-0.922,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":30.9,"tier":"low","components":{"pct_book":{"value":0.598,"points":20.91},"rank_top10":{"value":35,"points":0.0},"tilt":{"value":-0.922,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RAPP","issuer":"Rapport Therapeutics, Inc.","shares":1547090.0,"value_usd":48408446.0,"pct_book":0.28,"position_rank":36,"tilt_pp":-0.933,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":30.1,"tier":"low","components":{"pct_book":{"value":0.573,"points":20.06},"rank_top10":{"value":36,"points":0.0},"tilt":{"value":-0.933,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALMS","issuer":"Alumis Inc.","shares":2012500.0,"value_usd":44335375.0,"pct_book":0.25,"position_rank":37,"tilt_pp":-0.957,"action":"add","shares_change_pct":28.8,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.6,"tier":"low","components":{"pct_book":{"value":0.561,"points":19.63},"rank_top10":{"value":37,"points":0.0},"tilt":{"value":-0.957,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MIRM","issuer":"Mirum Pharmaceuticals, Inc.","shares":445975.0,"value_usd":41199171.0,"pct_book":0.24,"position_rank":38,"tilt_pp":-0.975,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":34.2,"tier":"low","components":{"pct_book":{"value":0.549,"points":19.21},"rank_top10":{"value":38,"points":0.0},"tilt":{"value":-0.975,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VRDN","issuer":"Viridian Therapeutics, Inc.","shares":1971678.0,"value_usd":38566022.0,"pct_book":0.22,"position_rank":39,"tilt_pp":-0.99,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":28.8,"tier":"low","components":{"pct_book":{"value":0.537,"points":18.78},"rank_top10":{"value":39,"points":0.0},"tilt":{"value":-0.99,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ELVN","issuer":"Enliven Therapeutics, Inc.","shares":905191.0,"value_usd":35483487.0,"pct_book":0.2,"position_rank":40,"tilt_pp":-1.008,"action":"add","shares_change_pct":233.5,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":38.4,"tier":"low","components":{"pct_book":{"value":0.524,"points":18.35},"rank_top10":{"value":40,"points":0.0},"tilt":{"value":-1.008,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"PRLD","issuer":"Prelude Therapeutics Inc.","shares":10123824.0,"value_usd":34623478.0,"pct_book":0.2,"position_rank":41,"tilt_pp":-1.012,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":28.4,"tier":"low","components":{"pct_book":{"value":0.524,"points":18.35},"rank_top10":{"value":41,"points":0.0},"tilt":{"value":-1.012,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DBVT","issuer":"DBV Technologies S.A.","shares":1461425.0,"value_usd":30529168.0,"pct_book":0.18,"position_rank":42,"tilt_pp":-1.036,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":27.5,"tier":"low","components":{"pct_book":{"value":0.5,"points":17.5},"rank_top10":{"value":42,"points":0.0},"tilt":{"value":-1.036,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DSGN","issuer":"Design Therapeutics, Inc.","shares":2585978.0,"value_usd":27514806.0,"pct_book":0.16,"position_rank":43,"tilt_pp":-1.053,"action":"add","shares_change_pct":15.8,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":37.1,"tier":"low","components":{"pct_book":{"value":0.488,"points":17.07},"rank_top10":{"value":43,"points":0.0},"tilt":{"value":-1.053,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"260","issuer":"Centessa Pharmaceuticals plc","shares":670751.0,"value_usd":26642230.0,"pct_book":0.15,"position_rank":44,"tilt_pp":-1.058,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.6,"tier":"low","components":{"pct_book":{"value":0.476,"points":16.65},"rank_top10":{"value":44,"points":0.0},"tilt":{"value":-1.058,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CTMX","issuer":"CytomX Therapeutics, Inc.","shares":4975826.0,"value_usd":23386382.0,"pct_book":0.13,"position_rank":45,"tilt_pp":-1.077,"action":"add","shares_change_pct":17.1,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":31.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.22},"rank_top10":{"value":45,"points":0.0},"tilt":{"value":-1.077,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"JBIO","issuer":"Jade Biosciences, Inc.","shares":1641137.0,"value_usd":23057975.0,"pct_book":0.13,"position_rank":46,"tilt_pp":-1.079,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.22},"rank_top10":{"value":46,"points":0.0},"tilt":{"value":-1.079,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IRON","issuer":"Disc Medicine, Inc.","shares":349657.0,"value_usd":22357069.0,"pct_book":0.13,"position_rank":47,"tilt_pp":-1.083,"action":"hold","shares_change_pct":3.7,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.22},"rank_top10":{"value":47,"points":0.0},"tilt":{"value":-1.083,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"IMCR","issuer":"Immunocore Holdings plc","shares":734397.0,"value_usd":22142070.0,"pct_book":0.13,"position_rank":48,"tilt_pp":-1.084,"action":"trim","shares_change_pct":-68.4,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.2,"tier":"low","components":{"pct_book":{"value":0.463,"points":16.22},"rank_top10":{"value":48,"points":0.0},"tilt":{"value":-1.084,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"XENE","issuer":"Xenon Pharmaceuticals Inc.","shares":370208.0,"value_usd":21527595.0,"pct_book":0.12,"position_rank":49,"tilt_pp":-1.088,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":24.5,"tier":"low","components":{"pct_book":{"value":0.415,"points":14.51},"rank_top10":{"value":49,"points":0.0},"tilt":{"value":-1.088,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CLDX","issuer":"Celldex Therapeutics, Inc.","shares":665370.0,"value_usd":21105536.0,"pct_book":0.12,"position_rank":50,"tilt_pp":-1.09,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":24.5,"tier":"low","components":{"pct_book":{"value":0.415,"points":14.51},"rank_top10":{"value":50,"points":0.0},"tilt":{"value":-1.09,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"NGNE","issuer":"Neurogene Inc.","shares":991691.0,"value_usd":19992491.0,"pct_book":0.11,"position_rank":51,"tilt_pp":-1.096,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.7,"tier":"low","components":{"pct_book":{"value":0.39,"points":13.66},"rank_top10":{"value":51,"points":0.0},"tilt":{"value":-1.096,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EVMN","issuer":"Evommune, Inc.","shares":847390.0,"value_usd":19481496.0,"pct_book":0.11,"position_rank":52,"tilt_pp":-1.099,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.7,"tier":"low","components":{"pct_book":{"value":0.39,"points":13.66},"rank_top10":{"value":52,"points":0.0},"tilt":{"value":-1.099,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"TECX","issuer":"Tectonic Therapeutic, Inc.","shares":607788.0,"value_usd":18786727.0,"pct_book":0.11,"position_rank":53,"tilt_pp":-1.103,"action":"trim","shares_change_pct":-32.7,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.7,"tier":"low","components":{"pct_book":{"value":0.39,"points":13.66},"rank_top10":{"value":53,"points":0.0},"tilt":{"value":-1.103,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CTNM","issuer":"Contineum Therapeutics, Inc.","shares":1420838.0,"value_usd":18556144.0,"pct_book":0.11,"position_rank":54,"tilt_pp":-1.105,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.7,"tier":"low","components":{"pct_book":{"value":0.39,"points":13.66},"rank_top10":{"value":54,"points":0.0},"tilt":{"value":-1.105,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ARGX","issuer":"argenx SE","shares":25174.0,"value_usd":18383314.0,"pct_book":0.11,"position_rank":55,"tilt_pp":-1.106,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":23.7,"tier":"low","components":{"pct_book":{"value":0.39,"points":13.66},"rank_top10":{"value":55,"points":0.0},"tilt":{"value":-1.106,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CERS","issuer":"Cerus Corporation","shares":10008345.0,"value_usd":18215188.0,"pct_book":0.1,"position_rank":56,"tilt_pp":-1.107,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":21.5,"tier":"low","components":{"pct_book":{"value":0.329,"points":11.52},"rank_top10":{"value":56,"points":0.0},"tilt":{"value":-1.107,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TSHA","issuer":"Taysha Gene Therapies, Inc.","shares":4004756.0,"value_usd":17901259.0,"pct_book":0.1,"position_rank":57,"tilt_pp":-1.108,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":21.5,"tier":"low","components":{"pct_book":{"value":0.329,"points":11.52},"rank_top10":{"value":57,"points":0.0},"tilt":{"value":-1.108,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"AKTS","issuer":"Aktis Oncology, Inc.","shares":996351.0,"value_usd":17824719.0,"pct_book":0.1,"position_rank":58,"tilt_pp":-1.109,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.5,"tier":"low","components":{"pct_book":{"value":0.329,"points":11.52},"rank_top10":{"value":58,"points":0.0},"tilt":{"value":-1.109,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"GENB","issuer":"Generate Biomedicines, Inc.","shares":1423602.0,"value_usd":17795025.0,"pct_book":0.1,"position_rank":59,"tilt_pp":-1.109,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.5,"tier":"low","components":{"pct_book":{"value":0.329,"points":11.52},"rank_top10":{"value":59,"points":0.0},"tilt":{"value":-1.109,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"SION","issuer":"Sionna Therapeutics, Inc.","shares":400000.0,"value_usd":16036000.0,"pct_book":0.09,"position_rank":60,"tilt_pp":-1.119,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.8,"tier":"low","components":{"pct_book":{"value":0.28,"points":9.82},"rank_top10":{"value":60,"points":0.0},"tilt":{"value":-1.119,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"DYN","issuer":"Dyne Therapeutics, Inc.","shares":813449.0,"value_usd":14747830.0,"pct_book":0.08,"position_rank":61,"tilt_pp":-1.127,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.4,"tier":"low","components":{"pct_book":{"value":0.268,"points":9.39},"rank_top10":{"value":61,"points":0.0},"tilt":{"value":-1.127,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"XNCR","issuer":"Xencor, Inc.","shares":1102106.0,"value_usd":13291398.0,"pct_book":0.08,"position_rank":62,"tilt_pp":-1.135,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":0.6725,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":19.4,"tier":"low","components":{"pct_book":{"value":0.268,"points":9.39},"rank_top10":{"value":62,"points":0.0},"tilt":{"value":-1.135,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"CMPS","issuer":"COMPASS Pathways plc","shares":2344720.0,"value_usd":12966302.0,"pct_book":0.07,"position_rank":63,"tilt_pp":-1.137,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":"Healthcare","themes":[{"key":"fv:healthcaretherapeutics","name":"Therapeutics","name_zh":"Therapeutics"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":13.5,"tier":"low","components":{"pct_book":{"value":0.244,"points":8.54},"rank_top10":{"value":63,"points":0.0},"tilt":{"value":-1.137,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"RLAY","issuer":"Relay Therapeutics, Inc.","shares":1160117.0,"value_usd":11543164.0,"pct_book":0.07,"position_rank":64,"tilt_pp":-1.145,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.5,"tier":"low","components":{"pct_book":{"value":0.244,"points":8.54},"rank_top10":{"value":64,"points":0.0},"tilt":{"value":-1.145,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SERA","issuer":"Sera Prognostics, Inc.","shares":5498170.0,"value_usd":11161285.0,"pct_book":0.06,"position_rank":65,"tilt_pp":-1.147,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":17.7,"tier":"low","components":{"pct_book":{"value":0.22,"points":7.68},"rank_top10":{"value":65,"points":0.0},"tilt":{"value":-1.147,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"BNTX","issuer":"BioNTech SE","shares":119743.0,"value_usd":10642758.0,"pct_book":0.06,"position_rank":66,"tilt_pp":-1.15,"action":"trim","shares_change_pct":-67.5,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[{"key":"fv:healthcarenextgen","name":"Next-Gen","name_zh":"Next-Gen"},{"key":"fv:healthcareoncology","name":"Oncology","name_zh":"Oncology"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":17.7,"tier":"low","components":{"pct_book":{"value":0.22,"points":7.68},"rank_top10":{"value":66,"points":0.0},"tilt":{"value":-1.15,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"RCUS","issuer":"Arcus Biosciences, Inc.","shares":415621.0,"value_usd":8977414.0,"pct_book":0.05,"position_rank":67,"tilt_pp":-1.16,"action":"add","shares_change_pct":53.9,"add_streak_q":2,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":0.1807,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":26.8,"tier":"low","components":{"pct_book":{"value":0.195,"points":6.83},"rank_top10":{"value":67,"points":0.0},"tilt":{"value":-1.16,"points":0.0},"add_streak":{"value":2,"points":10.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"MPLT","issuer":"MapLight Therapeutics, Inc.","shares":364705.0,"value_usd":7414453.0,"pct_book":0.04,"position_rank":68,"tilt_pp":-1.169,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.4,"tier":"low","components":{"pct_book":{"value":0.183,"points":6.4},"rank_top10":{"value":68,"points":0.0},"tilt":{"value":-1.169,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ABSI","issuer":"Absci Corporation","shares":2134803.0,"value_usd":6404409.0,"pct_book":0.04,"position_rank":69,"tilt_pp":-1.174,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":16.4,"tier":"low","components":{"pct_book":{"value":0.183,"points":6.4},"rank_top10":{"value":69,"points":0.0},"tilt":{"value":-1.174,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"WVE","issuer":"Wave Life Sciences Ltd.","shares":822638.0,"value_usd":5964126.0,"pct_book":0.03,"position_rank":70,"tilt_pp":-1.177,"action":"add","shares_change_pct":139.1,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":20.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":70,"points":0.0},"tilt":{"value":-1.177,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VTVT","issuer":"vTv Therapeutics, Inc.","shares":148314.0,"value_usd":5882133.0,"pct_book":0.03,"position_rank":71,"tilt_pp":-1.177,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":71,"points":0.0},"tilt":{"value":-1.177,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"EIKN","issuer":"Eikon Therapeutics, Inc.","shares":555555.0,"value_usd":5877772.0,"pct_book":0.03,"position_rank":72,"tilt_pp":-1.177,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"pending","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":10.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":72,"points":0.0},"tilt":{"value":-1.177,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"pending","points":0.0}}}},{"ticker":"TARA","issuer":"Protara Therapeutics, Inc.","shares":971614.0,"value_usd":5062109.0,"pct_book":0.03,"position_rank":73,"tilt_pp":-1.182,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":73,"points":0.0},"tilt":{"value":-1.182,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SGMT","issuer":"Sagimet Biosciences Inc.","shares":952996.0,"value_usd":4979404.0,"pct_book":0.03,"position_rank":74,"tilt_pp":-1.183,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":74,"points":0.0},"tilt":{"value":-1.183,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"LBRX","issuer":"LB Pharmaceuticals Inc.","shares":200000.0,"value_usd":4932000.0,"pct_book":0.03,"position_rank":75,"tilt_pp":-1.183,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":15.5,"tier":"low","components":{"pct_book":{"value":0.159,"points":5.55},"rank_top10":{"value":75,"points":0.0},"tilt":{"value":-1.183,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"VSTM","issuer":"Verastem, Inc.","shares":584757.0,"value_usd":3099212.0,"pct_book":0.02,"position_rank":76,"tilt_pp":-1.193,"action":"new","shares_change_pct":null,"add_streak_q":1,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":18.0,"tier":"low","components":{"pct_book":{"value":0.085,"points":2.99},"rank_top10":{"value":76,"points":0.0},"tilt":{"value":-1.193,"points":0.0},"add_streak":{"value":1,"points":5.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TCRX","issuer":"TScan Therapeutics, Inc.","shares":2784792.0,"value_usd":2812640.0,"pct_book":0.02,"position_rank":77,"tilt_pp":-1.195,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":13.0,"tier":"low","components":{"pct_book":{"value":0.085,"points":2.99},"rank_top10":{"value":77,"points":0.0},"tilt":{"value":-1.195,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SKYE","issuer":"Skye Bioscience, Inc.","shares":1575243.0,"value_usd":968144.0,"pct_book":0.01,"position_rank":78,"tilt_pp":-1.206,"action":"hold","shares_change_pct":8.6,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":12.1,"tier":"low","components":{"pct_book":{"value":0.061,"points":2.13},"rank_top10":{"value":78,"points":0.0},"tilt":{"value":-1.206,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SANA","issuer":"Sana Biotechnology, Inc.","shares":310483.0,"value_usd":894191.0,"pct_book":0.01,"position_rank":79,"tilt_pp":-1.206,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[{"key":"fv:healthcaretherapeutics","name":"Therapeutics","name_zh":"Therapeutics"}],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":12.1,"tier":"low","components":{"pct_book":{"value":0.061,"points":2.13},"rank_top10":{"value":79,"points":0.0},"tilt":{"value":-1.206,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"ALGS","issuer":"Aligos Therapeutics, Inc.","shares":83055.0,"value_usd":617099.0,"pct_book":0.0,"position_rank":80,"tilt_pp":-1.208,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.28},"rank_top10":{"value":80,"points":0.0},"tilt":{"value":-1.208,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"TYRA","issuer":"Tyra Biosciences, Inc.","shares":10607.0,"value_usd":406248.0,"pct_book":0.0,"position_rank":81,"tilt_pp":-1.209,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":"Healthcare","themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.28},"rank_top10":{"value":81,"points":0.0},"tilt":{"value":-1.209,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}},{"ticker":"SRZNW","issuer":"Surrozen, Inc.","shares":833333.0,"value_usd":13333.0,"pct_book":0.0,"position_rank":82,"tilt_pp":-1.211,"action":"hold","shares_change_pct":0.0,"add_streak_q":0,"persistence":"persisted","sector":null,"themes":[],"since_excess":null,"period_end":"2026-03-31","filing_date":"2026-05-15","conviction":{"score":11.3,"tier":"low","components":{"pct_book":{"value":0.037,"points":1.28},"rank_top10":{"value":82,"points":0.0},"tilt":{"value":-1.211,"points":0.0},"add_streak":{"value":0,"points":0.0},"new_at_size":{"value":false,"points":0.0},"persisted":{"value":"persisted","points":10.0}}}}],"book_meta":{"n_positions":84,"n_resolved":82,"resolution_pct":97.6,"book_value_usd":17415689929.0,"filing_date":"2026-05-15","period_end":"2026-03-31"},"sector_series":[{"period_end":"2023-03-31","filing_date":"2023-05-15","weights":{"Unclassified":56.2,"Healthcare":43.8},"top_theme_weights":{"US Sectors (EW)":14.22}},{"period_end":"2023-06-30","filing_date":"2023-08-14","weights":{"Unclassified":55.26,"Healthcare":44.74},"top_theme_weights":{"US Sectors (EW)":13.14}},{"period_end":"2023-09-30","filing_date":"2023-11-14","weights":{"Unclassified":58.7,"Healthcare":41.3},"top_theme_weights":{"US Sectors (EW)":12.14}},{"period_end":"2023-12-31","filing_date":"2024-02-14","weights":{"Healthcare":89.9,"Unclassified":10.1},"top_theme_weights":{"US Sectors (EW)":26.26,"Healthcare":0.01}},{"period_end":"2024-03-31","filing_date":"2024-05-15","weights":{"Healthcare":90.36,"Unclassified":9.64},"top_theme_weights":{"US Sectors (EW)":25.86,"Healthcare":0.01}},{"period_end":"2024-06-30","filing_date":"2024-08-14","weights":{"Healthcare":92.46,"Unclassified":7.54},"top_theme_weights":{"US Sectors (EW)":24.27,"Healthcare":0.01}},{"period_end":"2024-09-30","filing_date":"2024-11-14","weights":{"Healthcare":93.58,"Unclassified":6.42},"top_theme_weights":{"US Sectors (EW)":21.27,"Healthcare":0.05}},{"period_end":"2024-12-31","filing_date":"2025-02-14","weights":{"Healthcare":94.87,"Unclassified":5.13},"top_theme_weights":{"US Sectors (EW)":22.98,"Healthcare":0.11}},{"period_end":"2025-03-31","filing_date":"2025-05-15","weights":{"Healthcare":96.7,"Unclassified":3.3},"top_theme_weights":{"US Sectors (EW)":20.83,"Healthcare":0.07}},{"period_end":"2025-06-30","filing_date":"2025-08-14","weights":{"Healthcare":96.29,"Unclassified":3.71},"top_theme_weights":{"US Sectors (EW)":20.31,"Healthcare":0.5}},{"period_end":"2025-09-30","filing_date":"2025-11-14","weights":{"Healthcare":96.23,"Unclassified":3.77},"top_theme_weights":{"US Sectors (EW)":18.9,"Healthcare":0.39}},{"period_end":"2025-12-31","filing_date":"2026-02-17","weights":{"Healthcare":97.51,"Unclassified":2.49},"top_theme_weights":{"US Sectors (EW)":17.85,"Healthcare":0.59}},{"period_end":"2026-03-31","filing_date":"2026-05-15","weights":{"Healthcare":97.7,"Unclassified":2.3},"top_theme_weights":{"US Sectors (EW)":16.62,"Healthcare":0.4}}],"sector_rotation":{"into":[{"sector":"Healthcare","delta_pp":0.19}],"out_of":[],"deltas":{"Healthcare":0.19,"Unclassified":-0.19},"period_end":"2026-03-31","prev_period_end":"2025-12-31","method_note":{"en":"Current sector/theme map applied to history \u2014 historical quarters are classified with today's sector and theme membership (survivorship-lite; past classification changes are not reconstructed).","zh":"\u4ee5\u5f53\u524d\u884c\u4e1a/\u4e3b\u9898\u6620\u5c04\u56de\u6eaf\u5386\u53f2\u2014\u2014\u5386\u53f2\u5b63\u5ea6\u6309\u4eca\u65e5\u7684\u884c\u4e1a\u4e0e\u4e3b\u9898\u6210\u5458\u5206\u7c7b\uff08\u8f7b\u5ea6\u5e78\u5b58\u8005\u53e3\u5f84\uff1b\u4e0d\u91cd\u5efa\u8fc7\u53bb\u7684\u5206\u7c7b\u53d8\u66f4\uff09\u3002"}},"theme_read":{"leans":[{"theme_key":"fv:healthcaretherapeutics","label":"Therapeutics","label_zh":"Therapeutics","category":"Healthcare & Biotech","source":"finviz","tickers":["CMPS"],"added_pp":0.07,"held_pp":0.08,"n_names":2}],"core":{"theme_key":"fv:healthcaretherapeutics","label":"Therapeutics","label_zh":"Therapeutics","category":"Healthcare & Biotech","source":"finviz","tickers":["CMPS"],"added_pp":0.07,"held_pp":0.08,"n_names":2},"narrative_en":"Core lean: Therapeutics \u2014 added CMPS (+0.1pp of book this quarter)","narrative_zh":"\u6838\u5fc3\u503e\u5411\uff1aTherapeutics \u2014 \u672c\u5b63\u5ea6\u52a0\u4ed3 CMPS\uff08\u5360\u7ec4\u5408 +0.1pp\uff09"}}